Unknown

Dataset Information

0

Detection of ligand binding hot spots on protein surfaces via fragment-based methods: application to DJ-1 and glucocerebrosidase.


ABSTRACT: The identification of hot spots, i.e., binding regions that contribute substantially to the free energy of ligand binding, is a critical step for structure-based drug design. Here we present the application of two fragment-based methods to the detection of hot spots for DJ-1 and glucocerebrosidase (GCase), targets for the development of therapeutics for Parkinson's and Gaucher's diseases, respectively. While the structures of these two proteins are known, binding information is lacking. In this study we employ the experimental multiple solvent crystal structures (MSCS) method and computational fragment mapping (FTMap) to identify regions suitable for the development of pharmacological chaperones for DJ-1 and GCase. Comparison of data derived via MSCS and FTMap also shows that FTMap, a computational method for the identification of fragment binding hot spots, is an accurate and robust alternative to the performance of expensive and difficult crystallographic experiments.

SUBMITTER: Landon MR 

PROVIDER: S-EPMC2889209 | biostudies-literature | 2009 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Detection of ligand binding hot spots on protein surfaces via fragment-based methods: application to DJ-1 and glucocerebrosidase.

Landon Melissa R MR   Lieberman Raquel L RL   Hoang Quyen Q QQ   Ju Shulin S   Caaveiro Jose M M JM   Orwig Susan D SD   Kozakov Dima D   Brenke Ryan R   Chuang Gwo-Yu GY   Beglov Dmitry D   Vajda Sandor S   Petsko Gregory A GA   Ringe Dagmar D  

Journal of computer-aided molecular design 20090612 8


The identification of hot spots, i.e., binding regions that contribute substantially to the free energy of ligand binding, is a critical step for structure-based drug design. Here we present the application of two fragment-based methods to the detection of hot spots for DJ-1 and glucocerebrosidase (GCase), targets for the development of therapeutics for Parkinson's and Gaucher's diseases, respectively. While the structures of these two proteins are known, binding information is lacking. In this  ...[more]

Similar Datasets

| S-EPMC3414429 | biostudies-literature
| S-EPMC3758163 | biostudies-literature
| S-EPMC3623692 | biostudies-literature
| S-EPMC10262261 | biostudies-literature
| S-EPMC3241411 | biostudies-literature
| S-EPMC2647826 | biostudies-literature
| S-EPMC6132223 | biostudies-literature
| S-EPMC3634182 | biostudies-literature
| S-EPMC9890547 | biostudies-literature
| S-EPMC3410406 | biostudies-literature